135 related articles for article (PubMed ID: 36605843)
1. Lenvatinib-refractory thymic mucinous carcinoma with
Tsukaguchi A; Ihara S; Yasuoka H; Minami S
Int Cancer Conf J; 2023 Jan; 12(1):36-40. PubMed ID: 36605843
[TBL] [Abstract][Full Text] [Related]
2. Successful resection after first-line lenvatinib therapy in an advanced thymic carcinoma.
Shimura M; Miura K; Koizumi T; Kanda S; Mishima S; Hara D; Matsuoka S; Eguchi T; Hamanaka K; Uehara T; Shimizu K
Thorac Cancer; 2023 Jun; 14(17):1640-1643. PubMed ID: 37132133
[TBL] [Abstract][Full Text] [Related]
3. Primary mucinous adenocarcinoma of the thymus: A case report.
Hamahiro T; Maeda R; Ayabe T; Sato Y; Tomita M
Respir Med Case Rep; 2021; 34():101497. PubMed ID: 34430195
[TBL] [Abstract][Full Text] [Related]
4. Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report.
Terashima Y; Hakozaki T; Takeuchi S; Hosomi Y
Thorac Cancer; 2022 Dec; 13(23):3408-3411. PubMed ID: 36251511
[TBL] [Abstract][Full Text] [Related]
5. Primary mucinous adenocarcinoma of the thymus; a rare type of thymic carcinoma. Case Report.
Tomoshige K; Tomoshi T; Keitaro M; Miyazaki T; Doi R; Machino R; Mizoguchi S; Matumoto T; Maeda Y; Nagayasu T
SN Compr Clin Med; 2021 May; 3(5):1233-1237. PubMed ID: 34151190
[TBL] [Abstract][Full Text] [Related]
6. Primary Thymic Mucinous Adenocarcinoma with Extensive Punctate and Amorphous Calcifications: A Case Report.
Cho H; Park J; Shin KM; Park SY; Park B; Jeong JY; Kim JH
Curr Med Imaging; 2024; 20():e060623217707. PubMed ID: 37282659
[TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus
Araya T; Kita T; Matsuoka H; Sakai T; Kimura H; Kasahara K
Case Rep Oncol; 2020; 13(3):1506-1512. PubMed ID: 33564291
[TBL] [Abstract][Full Text] [Related]
8.
Sakanoue I; Hamakawa H; Fujimoto D; Imai Y; Minami K; Tomii K; Takahashi Y
J Thorac Dis; 2017 Aug; 9(8):E694-E697. PubMed ID: 28932588
[TBL] [Abstract][Full Text] [Related]
9. Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial.
Sato J; Satouchi M; Itoh S; Okuma Y; Niho S; Mizugaki H; Murakami H; Fujisaka Y; Kozuki T; Nakamura K; Nagasaka Y; Kawasaki M; Yamada T; Machida R; Kuchiba A; Ohe Y; Yamamoto N
Lancet Oncol; 2020 Jun; 21(6):843-850. PubMed ID: 32502444
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Brain Metastasis of Thymic Carcinoma.
Mitsui T; Matsuda R; Goda K; Itami H; Nakagawa I; Nakase H
Anticancer Res; 2022 Feb; 42(2):1169-1174. PubMed ID: 35093922
[TBL] [Abstract][Full Text] [Related]
11. Primary mucinous adenocarcinoma of the vagina.
Nasu K; Kai K; Matsumoto H; Mori C; Takai N; Narahara H
Eur J Gynaecol Oncol; 2010; 31(6):679-81. PubMed ID: 21319516
[TBL] [Abstract][Full Text] [Related]
12. Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum.
Yanagihara T; Matsumoto K; Yoneda R; Egashira A; Mannoji H; Watanabe H; Hanaoka K; Nakayama Y; Ogo N; Inutsuka Y; Asoh T; Kohashi K; Kinoshita I; Oda Y; Maeyama T
Respir Med Case Rep; 2021; 33():101477. PubMed ID: 34401310
[TBL] [Abstract][Full Text] [Related]
13. Calcified mucinous adenocarcinoma of the stomach metastatic to the iris: a case report.
Kaneko M; Namisaki T; Takaya H; Mori H; Kitade M; Okura Y; Seki K; Sato S; Nakanishi K; Kitagawa K; Ozutsumi T; Shimozato N; Kaji K; Otani T; Nakai T; Obayashi C; Mitoro A; Yamao J; Yoshiji H
J Med Case Rep; 2019 Mar; 13(1):64. PubMed ID: 30841908
[TBL] [Abstract][Full Text] [Related]
14. First-Line Treatment with Carboplatin plus
Funaishi K; Yamasaki M; Saito N; Daido W; Ishiyama S; Deguchi N; Taniwaki M; Ohashi N
Case Rep Oncol; 2017; 10(2):571-576. PubMed ID: 28868014
[TBL] [Abstract][Full Text] [Related]
15. Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report.
Nishii Y; Furuhashi K; Ito K; Sakaguchi T; Suzuki Y; Fujiwara K; Yasuma T; Kobayashi T; D'Alessandro-Gabazza CN; Gabazza EC; Taguchi O; Hataji O
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890187
[TBL] [Abstract][Full Text] [Related]
16. Successful chemotherapy with Carboplatin and s-1 for thymic carcinoma: a case report.
Igawa S; Yanagisawa N; Ishihara M; Kimura M; Maki S; Otani S; Sasaki J; Masuda N
Case Rep Oncol; 2013; 6(3):526-30. PubMed ID: 24348388
[TBL] [Abstract][Full Text] [Related]
17. A rare case of gastric-type mucinous endocervical adenocarcinoma in a 59-year-old woman.
Mulita F; Iliopoulos F; Kehagias I
Prz Menopauzalny; 2020 Sep; 19(3):147-150. PubMed ID: 33100952
[TBL] [Abstract][Full Text] [Related]
18. Thymic Adenocarcinoma with Positivity for Thyroid Transcription Factor-1 and a BRAF V600E Mutation.
Yorozuya T; Otsuka M; Ichihara S; Fujimori K; Kitamura C; Takahashi T; Mori M; Cho Y; Chiba H
Intern Med; 2022 Feb; 61(3):385-388. PubMed ID: 34275983
[TBL] [Abstract][Full Text] [Related]
19. Long-term management of recurrent papillary thyroid carcinoma treated with lenvatinib for over 5 years: a case report.
Imai T; Kobayashi H; Senaha T; Imaizumi T; Murata Y
Surg Case Rep; 2022 Jan; 8(1):21. PubMed ID: 35084585
[TBL] [Abstract][Full Text] [Related]
20. Surgical resection combined with perioperative chemotherapy for a patient with locally recurrent, previously stage IV thymic small-cell carcinoma: A case report.
Terada J; Toyoda Y; Takeuchi E; Tanida N; Ito S; Yorita K; Matsuoka H; Bando H; Morita Y; Okamoto Y; Shinohara T
Thorac Cancer; 2022 Dec; 13(23):3415-3419. PubMed ID: 36345130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
